Clinical trials: Enlarged Prostate (BPH)

Benign Prostatic Hyperplasia (BPH)

Phase 4 Study of Greenlight XPS Laser Versus BiVAP Saline Vaporization of the Prostate in Men With Symptomatic Benign Prostatic Hyperplasia

• Completed
• Age: 18 years and older
• Phase 4
• Medical device
• Results posted

This is a Phase 4, prospective, open-label, randomized study of Greenlight XPS Laser versus BiVAP Saline Vaporization of the prostate in men with symptomatic Benign Prostatic Hyperplasia (BPH).

Trial name

NCT01500057

Testing

Greenlight XPS Laser, BiVAP Saline Vaporization of the prostate

Where

United States

Volunteers

66 people, healthy volunteers welcome

Sponsor

Brooklyn Urology Research Group